Globus Medical Inc - Class A

Research Globus Medical Inc - Class A (GMED) on Bullrun: valuation model: 17.2% undervalued, market cap USD 11.14B, P/E 21.2. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerGMED
ExchangeNYSE
CountryUnited States
SectorHealthcare
IndustryMedical Devices
CurrencyUSD
Valuation signal17.2% undervalued
Market capUSD 11.14B
P/E21.2
Financial periodQ2 2026
RevenueUSD 789.61M
Net incomeUSD 151.57M
Free cash flowUSD 176.57M
Gross margin69.4%

Valuation Snapshot

Bullrun's latest valuation model marks Globus Medical Inc - Class A as 17.2% undervalued; latest market cap is USD 11.14B; P/E is 21.2.

Peer valuation comparison

Latest P/E is 21.21x versus a Healthcare sector median of 24.46x (13.3% below).

Latest P/E is 21.21x versus a United States median of 24.87x (14.7% below).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	USD 2.94B	USD 537.87M	USD 588.77M	67.4%	3.92	USD 526.16M	USD 118.66M	USD 4.57B
FY2024	USD 2.52B	USD 102.98M	USD 405.21M	58.9%	0.75	USD 784.44M	USD 537.19M	USD 4.18B
FY2023	USD 1.57B	USD 122.87M	USD 165.23M	65.1%	1.07	USD 467.29M	USD 520.40M	USD 4.00B
FY2022	USD 1.02B	USD 190.17M	USD 104.42M	74.2%	1.85	USD 150.47M	USD 6.01M	USD 1.85B

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-25	USD 11.14B	21.2	n/a	n/a
2025	2025-12-31	USD 11.79B	22.2	n/a	n/a
2024	2024-12-31	USD 11.37B	111.8	n/a	n/a
2023	2023-12-29	USD 7.34B	34.4	n/a	n/a
2022	2022-12-30	USD 7.42B	49.2	n/a	n/a
2021	2021-12-31	USD 7.33B	50.1	n/a	n/a

About Globus Medical Inc - Class A

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices;

Related stock research

United States stocks United States Healthcare stocks A-Z stock index

Other Healthcare stocks

ESTABLISHMENT LABS HLDGS (3E0) Senseonics Holdings Inc. (6L60) Abbott Laboratories (ABT) Adagio Medical Holdings Inc (ADGM) Aethlon Medical Inc (AEMD) AdaptHealth Corp (AHCO) Alamar Biosciences, Inc. (ALMR) Allurion Technologies Inc (ALUR) Autonomix Medical Inc (AMIX) Artivion Inc (AORT) AOTI Inc (AOTI) Apyx Medical Corp (APYX)

Frequently asked questions

Is Globus Medical Inc - Class A overvalued or undervalued?

Bullrun's valuation model currently marks Globus Medical Inc - Class A as 17.2% undervalued.

What is Globus Medical Inc - Class A's market cap?

Globus Medical Inc - Class A's market capitalization is USD 11.14B.

What is Globus Medical Inc - Class A's P/E ratio?

Globus Medical Inc - Class A's price-to-earnings (P/E) ratio is 21.2.

What does Globus Medical Inc - Class A do?

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.